PTC Therapeutics | PTCT - Trade Creditors


PTC Therapeutics reported $41.59M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 16.33M 28.24M Sep/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amgen USD 20.83B 17.97B Sep/2026
BioCryst Pharmaceuticals USD 14.58M 3.12M Sep/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Cytokinetics USD 25.96M 5.45M Sep/2026
Daiichi Sankyo JPY 612.24B 73.19B Sep/2026
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Gilead Sciences USD 934M 260M Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Ionis Pharmaceuticals USD 27.11M 20.59M Sep/2026
Ironwood Pharmaceuticals USD 3.62M 2.7M Sep/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Novartis USD 4.24B 15M Sep/2026
Pfizer USD 4.07B 511M Sep/2026
PTC Therapeutics USD 41.59M 1.14M Sep/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 45.7M 5.28M Sep/2026
TG Therapeutics USD 213.69M 64.85M Jun/2026
Ultragenyx Pharmaceutical USD 45M 6M Sep/2026
Vertex Pharmaceuticals USD 3.71B 99.2M Sep/2026
Xencor USD 6.65M 6M Sep/2026